| Instrument | Return 1W | Market Cap | P/E Ratio | Revenue | EPS | Dividend |
|---|---|---|---|---|---|---|
 Eli Lilly (LLY) | -10.25% | $700B | 64.25 | - | - | 0% |
 Johnson & Johnson (JNJ) | -6.4% | $369B | 26.43 | - | - | 0% |
 AbbVie (ABBV) | -8.93% | $331B | 78.17 | - | - | 0% |
 Novo Nordisk (NOVO-B.CO) | -8.87% | $281B | 19.05 | - | - | 0% |
 Roche bearer shares (RO.ZU) | -11.3% | $256B | 26.74 | - | - | 0% |
 Roche (ROG.ZU) | -11.76% | $242B | 25.2 | - | - | 0% |
 AstraZeneca (AZN.L) | -5.33% | $216B | 30.37 | - | - | 0% |
 AstraZeneca (AZN) | -7.22% | $212B | 30.16 | - | - | 0% |
 Novo-Nordisk (NVO) | -9.74% | $210B | 19.02 | - | - | 0% |
 Merck (MRK) | -8.7% | $206B | 12.1 | - | - | 0% |
 Novartis (NVS) | -5.97% | $201B | 17.9 | - | - | 0% |
 Pfizer (PFE) | -8.89% | $130B | 16.32 | - | - | 0% |
 Sanofi (SAN.PA) | -7.16% | $128B | 21.61 | - | - | 0% |
 Sanofi (SNY) | -6.88% | $127B | 21.63 | - | - | 0% |
 Vertex (VRTX) | -3.67% | $122B | -215.57 | - | - | 0% |
 Bristol-Myers Squibb (BMY) | -7.86% | $113B | -12.49 | - | - | 0% |
 GlaxoSmithKline (GSK) | -5.7% | $74.3B | 22.82 | - | - | 0% |
 GSK (GSK.L) | -4.77% | $74.1B | 22.43 | - | - | 0% |
 Zoetis (ZTS) | -6.98% | $67.9B | 27.76 | - | - | 0% |
 Regeneron (REGN) | -10.03% | $62.7B | 14.98 | - | - | 0% |
 Merck (MRK.DE) | -9.8% | $56B | 18.44 | - | - | 0% |
 Takeda (TAK) | -2.19% | $46.7B | 34.04 | - | - | 0% |
 Haleon (HLN) | -3.42% | $44.7B | 24.51 | - | - | 0% |
 UCB (UCB.BR) | -8.34% | $31.3B | 26.87 | - | - | 0% |
 Alnylam (ALNY) | -12.19% | $30.7B | -108.52 | - | - | 0% |
 BeiGene (ONC) | -10.8% | $23.6B | -38.88 | - | - | 0% |
 Bayer (BAYN.DE) | -10.97% | $21.6B | -7.74 | - | - | 0% |
 Biogen (BIIB) | -11.12% | $18B | 11 | - | - | 0% |
 Sandoz (SDZNY) | -11.55% | $16.4B | -21111.11 | - | - | 0% |
 Sartorius (SRT3 GY) | +65.79% | $14.2B | 154.41 | - | - | 0% |
 United Therapeutics (UTHR) | -4.73% | $13.1B | 11.89 | - | - | 0% |
 Insmed (INSM) | -11.3% | $12.5B | -12.38 | - | - | 0% |
 Incyte (INCY) | -0.03% | $11.7B | 223.38 | - | - | 0% |
 Genmab (GMAB.US) | -7.59% | $11.7B | 10.39 | - | - | 0% |
 Genmab (GMAB.CO) | -8.25% | $11.7B | 10.21 | - | - | 0% |
 Sartorius (SRT.DE) | -13.57% | $11.4B | 124.55 | - | - | 0% |
 Recordati (REC.MI) | -4.88% | $11.4B | 24.67 | - | - | 0% |
 Innovent Biologics (1801.HK) | +9.6% | $10.6B | -800.16 | - | - | 0% |
 Dr. Reddy's (RDY) | -6.36% | $10.3B | 16.06 | - | - | 0% |
 Akeso (9926.HK) | +21.07% | $9.9B | -131.05 | - | - | 0% |
 Exelixis (EXEL) | -5.8% | $9.68B | 19.5 | - | - | 0% |
 Neurocrine Biosciences (NBIX) | -15.47% | $9.54B | 29.06 | - | - | 0% |
 Sobi (SOBI.ST) | -5.76% | $9.41B | 24.23 | - | - | 0% |
 Ipsen (IPN.PA) | -4.28% | $9.3B | 24.62 | - | - | 0% |
 Sino Bio (01177.HK) | +6.58% | $9.17B | 37.05 | - | - | 0% |
 Viatris (VTRS) | -12.21% | $9.1B | -14.28 | - | - | 0% |
 Ascendis Pharma (ASND) | -7.76% | $8.54B | -20 | - | - | 0% |
 Orion (ORNBV.HE) | -4.12% | $8.07B | 22.38 | - | - | 0% |
 Corcept Therapeutics (CORT) | +36.28% | $7.85B | 60.38 | - | - | 0% |
 Madrigal (MDGL) | -4.11% | $6.94B | -14.22 | - | - | 0% |
 Roivant Sciences (ROIV) | -8.86% | $6.75B | -65.29 | - | - | 0% |
 Jazz Pharmaceuticals (JAZZ) | -10.48% | $6.68B | 12.65 | - | - | 0% |
 Repligen (RGEN) | -16.09% | $6.29B | -245.32 | - | - | 0% |
 Grifols (GRF.MC) | -5.39% | $6.04B | 35.09 | - | - | 0% |
 Legend Biotech (LEGN) | -8.7% | $5.88B | -33.06 | - | - | 0% |
 TG Therapeutics (TGTX) | -6.3% | $5.87B | 267.55 | - | - | 0% |
 Fosun Pharma (02196.HK) | +3.97% | $5.37B | 12.19 | - | - | 0% |
 Sarepta (SRPT) | -22.7% | $5.28B | 22.84 | - | - | 0% |
 Alkermes (ALKS) | -9.49% | $4.89B | 13.79 | - | - | 0% |
 Verona Pharma (VRNA) | -14.04% | $4.56B | -24.9 | - | - | 0% |
 Cytokinetics (CYTK) | -13.5% | $4.42B | -7.08 | - | - | 0% |
 Zealand Pharma A/S (ZEAL.CO) | -22.93% | $4.41B | -26.2 | - | - | 0% |
 Lundbeck (HLUNB.CO) | -17.43% | $4.4B | 9.57 | - | - | 0% |
 Ionis (IONS) | -13.03% | $4.31B | -8.91 | - | - | 0% |
 Prestige Consumer (PBH) | -2.63% | $4.1B | 19.41 | - | - | 0% |
 Perrigo (PRGO) | -6.24% | $3.59B | -22.06 | - | - | 0% |
 PTC Therapeutics (PTCT) | -20.28% | $3.41B | -9.14 | - | - | 0% |
 Organon (OGN.US) | -10.06% | $3.37B | 3.91 | - | - | 0% |
 Soleno Therapeutics (SLNO) | -6.26% | $3.09B | -15.84 | - | - | 0% |
 Ultragenyx (RARE.US) | -14.25% | $3B | -5.12 | - | - | 0% |
 Hutchmed (HCM.L) | +3.91% | $2.98B | -68.73 | - | - | 0% |
 Akero (AKRO) | -14.02% | $2.92B | -9.8 | - | - | 0% |
 Catalyst Pharmaceuticals (CPRX) | -6.56% | $2.8B | 17.63 | - | - | 0% |
 ROVI (ROVI.MC) | -6.23% | $2.74B | 18.72 | - | - | 0% |
 ACADIA (ACAD) | -9.9% | $2.57B | 11.31 | - | - | 0% |
 Viking Therapeutics (VKTX) | -11.81% | $2.54B | -22.42 | - | - | 0% |
 HUTCHMED (HCM) | -5.7% | $2.51B | 66.54 | - | - | 0% |
 Apellis (APLS) | -17.72% | $2.51B | -12.49 | - | - | 0% |
 Crinetics (CRNX) | -22.57% | $2.5B | -7.26 | - | - | 0% |
 ImmunityBio (IBRX) | -9.87% | $2.42B | -4.48 | - | - | 0% |
 Provention Bio Inc (PRVB) | +3.05% | $2.37B | -16.32 | - | - | 0% |
 MoonLake (MLTX) | -6.65% | $2.35B | -19.69 | - | - | 0% |
 Amneal (AMRX) | -10.87% | $2.31B | -19.41 | - | - | 0% |
 Amicus Therapeutics (FOLD) | -11.03% | $2.3B | -40.69 | - | - | 0% |
 Xenon Pharmaceuticals (XENE) | -14.19% | $2.25B | -9.78 | - | - | 0% |
 Almirall (ALM.MC) | -7.7% | $2.17B | 190.47 | - | - | 0% |
 Vericel (VCEL) | -5.8% | $2.1B | 227.09 | - | - | 0% |
 Dermapharm (DMP.DE) | -4.82% | $2.09B | 16.82 | - | - | 0% |
 Mirum Pharmaceuticals (MIRM) | -8.61% | $2.06B | -22.68 | - | - | 0% |
 Tarsus (TARS) | -9.12% | $1.96B | -15.16 | - | - | 0% |
 Ligand (LGND) | -7.48% | $1.92B | -646.56 | - | - | 0% |
 Biohaven (BHVN) | -32.77% | $1.9B | -1.98 | - | - | 0% |
 Bellus Health Inc (BLU) | +0.14% | $1.87B | -20.45 | - | - | 0% |
 Supernus (SUPN) | +1.39% | $1.83B | 24.84 | - | - | 0% |
 Belite Bio (BLTE) | -14.69% | $1.81B | -48.13 | - | - | 0% |
 Arcutis (ARQT) | -6.36% | $1.75B | -12.67 | - | - | 0% |
 NewAmsterdam Pharma (NAMS) | -27.34% | $1.74B | -6.08 | - | - | 0% |
 Grifols (GRFS) | -8.53% | $1.72B | 26.52 | - | - | 0% |
 Harmony Biosciences (HRMY) | -11.84% | $1.68B | 11.66 | - | - | 0% |
 Bavarian Nordic A/S (BAVA.CO) | -9.91% | $1.65B | 11.37 | - | - | 0% |
 Centessa (CNTA) | -19.95% | $1.55B | -5.88 | - | - | 0% |
 Kiniksa (KNSA) | -11.82% | $1.48B | -33.62 | - | - | 0% |
 Agios (AGIO) | -14.93% | $1.48B | 2.26 | - | - | 0% |
 MannKind (MNKD) | -5.77% | $1.44B | 51.8 | - | - | 0% |
 Travere (TVTX) | -23.83% | $1.33B | -3.65 | - | - | 0% |
 Faes Farma (FAE.MC) | -2.75% | $1.32B | 10.87 | - | - | 0% |
 IDEAYA (IDYA) | -13.72% | $1.29B | -4.46 | - | - | 0% |
 Amphastar (AMPH) | -6.4% | $1.27B | 8.69 | - | - | 0% |
 ARS Pharmaceuticals (SPRY) | +2.48% | $1.26B | 166.88 | - | - | 0% |
 Indivior (INDV.L) | -2.86% | $1.15B | -34.38 | - | - | 0% |
 Eqrx Inc (EQRX) | 0% | $1.14B | -4.33 | - | - | 0% |
 Innoviva (INVA) | -2.53% | $1.11B | 84.7 | - | - | 0% |
 Liquidia (LQDA) | -14.51% | $1.1B | -7.78 | - | - | 0% |
 Ardelyx (ARDX) | -7.71% | $1.08B | -27.04 | - | - | 0% |
 Evotec (EVT.DE) | -8.08% | $1.07B | -5.7 | - | - | 0% |
 Pacira (PCRX) | -7.27% | $1.07B | -10.49 | - | - | 0% |
 Ocular Therapeutix (OCUL) | -16.16% | $1.01B | -5.04 | - | - | 0% |
 Cosmo Pharmaceuticals NV (C43.DE) | -2.54% | $1.01B | 6.93 | - | - | 0% |
 Vetoquinol SA (VETO.PA) | -6.17% | $984M | 15.38 | - | - | 0% |
 Viridian Therapeutics (VRDN) | -16.97% | $977M | -3.18 | - | - | 0% |
 Collegium (COLL) | -5.28% | $886M | 15.23 | - | - | 0% |
 89Bio (ETNB) | -28.59% | $842M | -1.68 | - | - | 0% |
 Harrow (HROW) | -10.26% | $839M | -47.7 | - | - | 0% |
 Phibro (PAHC) | -10.58% | $777M | 40.32 | - | - | 0% |
 Pharvaris (PHVS) | -9.62% | $771M | -5.33 | - | - | 0% |
 Zymeworks (ZYME) | -11.48% | $768M | -6.77 | - | - | 0% |
 Nurix (NRIX) | -20.25% | $735M | -3.35 | - | - | 0% |
 Day One (DAWN) | -10.53% | $732M | -6.95 | - | - | 0% |
 Evolus (EOLS) | -11.29% | $680M | -13.12 | - | - | 0% |
 Praxis (PRAX) | -15.55% | $658M | -3.18 | - | - | 0% |
 Avadel (AVDL) | -15.11% | $657M | -13.04 | - | - | 0% |
 GH Research (GHRS) | -8.77% | $626M | -13.47 | - | - | 0% |
 Arbutus (ABUS) | -7.71% | $618M | -8.56 | - | - | 0% |
 Gyre Therapeutics (GYRE) | -24.04% | $597M | 58.05 | - | - | 0% |
 KalVista (KALV) | -10.23% | $532M | -2.87 | - | - | 0% |
 Pharming Group NV (PHARM.NV) | -11.5% | $527M | -47.2 | - | - | 0% |
 Savara (SVRA) | -2.06% | $492M | -5.91 | - | - | 0% |
 Medincell SA (MEDCL.PA) | -10.56% | $484M | -12.38 | - | - | 0% |
 Akebia (AKBA) | -7.33% | $462M | -5.39 | - | - | 0% |
 Formycon (FYB.DE) | -3.58% | $442M | -3.21 | - | - | 0% |
 Cullinan Oncology (CGEM) | -7.61% | $434M | -2.36 | - | - | 0% |
 Alliance Pharma (APH.L) | +0.33% | $427M | -9.9 | - | - | 0% |
 Sage (SAGE) | -17.15% | $422M | -1.04 | - | - | 0% |
 Kindred Biosciences Inc (KIN) | +0.22% | $421M | -9.02 | - | - | 0% |
 Theravance (TBPH) | -8.56% | $418M | -7.31 | - | - | 0% |
 Capricor (CAPR) | -21.22% | $414M | -7.57 | - | - | 0% |
 Omeros (OMER) | -16.65% | $410M | -2.62 | - | - | 0% |
 Keros (KROS) | -7.51% | $405M | -1.99 | - | - | 0% |
 SIGA Technologies (SIGA) | -2.88% | $385M | 6.5 | - | - | 0% |
 Zevra (ZVRA) | -10.32% | $381M | -3.15 | - | - | 0% |
 Adamas Pharmaceuticals Inc (ADMS) | +0.24% | $376M | -4.85 | - | - | 0% |
 ORIC Pharmaceuticals (ORIC) | -20.52% | $347M | -2.67 | - | - | 0% |
 Phathom (PHAT) | -26.06% | $340M | -0.91 | - | - | 0% |
 Checkpoint Therapeutics (CKPT) | -0.74% | $336M | -3.15 | - | - | 0% |
 Erasca (ERAS) | -23.68% | $329M | -1.55 | - | - | 0% |
 PharmaSGP Holding SE (PSG.DE) | -0.82% | $317M | 15.43 | - | - | 0% |
 Eton (ETON) | -9.14% | $317M | -79.56 | - | - | 0% |
 EyePoint Pharmaceuticals (EYPT) | -20.93% | $317M | -1.99 | - | - | 0% |
 REGENXBIO (RGNX) | -19.67% | $315M | -1.36 | - | - | 0% |
 Rigel (RIGL) | -3.58% | $308M | 17.74 | - | - | 0% |
 Amylyx (AMLX) | -6.28% | $304M | -0.77 | - | - | 0% |
 Aquestive (AQST) | -10.26% | $268M | -5.23 | - | - | 0% |
 Astria (ATXS) | -18.33% | $263M | -2.76 | - | - | 0% |
 Atai (ATAI) | -10.88% | $260M | -1.63 | - | - | 0% |
 2Seventy Bio (TSVT) | 0% | $259M | -4.41 | - | - | 0% |
 Arcturus Therapeutics (ARCT) | -21.33% | $247M | -3.03 | - | - | 0% |
 Emergent BioSolutions (EBS) | -3% | $246M | -1.21 | - | - | 0% |
 Acelyrin (SLRN) | -6.54% | $245M | -0.97 | - | - | 0% |
 Esperion (ESPR) | -18% | $243M | -4.61 | - | - | 0% |
 Vanda (VNDA) | -11.73% | $241M | -12.74 | - | - | 0% |
 Atea (AVIR) | -4.78% | $239M | -1.4 | - | - | 0% |
 Chiasma Inc (CHMA) | -9.4% | $238M | -2.35 | - | - | 0% |
 Beximco Pharma (BXP.L) | +3.9% | $229M | 4.16 | - | - | 0% |
 Olema (OLMA) | -20.92% | $222M | -1.51 | - | - | 0% |
 Abeona Therapeutics (ABEO) | -9.05% | $219M | -2.01 | - | - | 0% |
 MindMed (MNMD) | +6.76% | $218M | -2.64 | - | - | 0% |
 Faron (FARN.L) | -6.09% | $218M | -4.53 | - | - | 0% |
 Ironwood Pharmaceuticals (IRWD) | -4.96% | $217M | 124.07 | - | - | 0% |
 Spectrum Pharmaceuticals Inc (SPPI) | +5.64% | $211M | -2.93 | - | - | 0% |
 Y-mAbs (YMAB) | -5.61% | $205M | -6.78 | - | - | 0% |
 Compass (CMPX) | -26.63% | $202M | -4.06 | - | - | 0% |
 Benchmark (BMK.L) | -17.6% | $196M | -4.66 | - | - | 0% |
 Lifecore Biomedical (LFCR) | -22.77% | $196M | -3.57 | - | - | 0% |
 Corvus Pharmaceuticals (CRVS) | -15.68% | $194M | -2.94 | - | - | 0% |
 Ocugen (OCGN) | -17.2% | $193M | -3.66 | - | - | 0% |
 Nuvectis Pharma (NVCT) | -21.13% | $193M | -7.67 | - | - | 0% |
 Benchmark Holdings PLC (BMK.OL) | -21.71% | $189M | -4.62 | - | - | 0% |
 Protalix (PLX) | -7.36% | $186M | 90.87 | - | - | 0% |
 Annexon (ANNX) | -24.89% | $185M | -1.67 | - | - | 0% |
 Gossamer Bio (GOSS) | -31.62% | $182M | -3.06 | - | - | 0% |
 Genfit (GNFT.PA) | -7.53% | $171M | 6.98 | - | - | 0% |
 Hyloris Pharmaceuticals SA (HYL.BR) | -7.8% | $167M | -24.02 | - | - | 0% |
 Journey Medical (DERM) | +17.68% | $166M | -9.66 | - | - | 0% |
 Innate Pharma SA (IPH.PA) | -7.41% | $158M | -2.82 | - | - | 0% |
 Third Harmonic (THRD) | -0.85% | $157M | -3.21 | - | - | 0% |
 Lexicon Pharmaceuticals (LXRX) | -26.57% | $151M | -0.65 | - | - | 0% |
 Aclaris Therapeutics (ACRS) | -11.95% | $151M | -0.93 | - | - | 0% |
 Newron Pharmaceuticals SpA (NP5.DE) | -19.43% | $148M | 8.97 | - | - | 0% |
 Puma Biotechnology (PBYI) | -7.64% | $144M | 4.75 | - | - | 0% |
 Heidelberg Pharma AG (HPHA.DE) | -0.71% | $143M | -6.76 | - | - | 0% |
 DBV Technologies (DBV.PA) | +16.48% | $141M | -1.16 | - | - | 0% |
 RAPT (RAPT) | -13.11% | $140M | -0.34 | - | - | 0% |
 Fulcrum Therapeutics (FULC) | -16.61% | $135M | -11.58 | - | - | 0% |
 Korro Bio (KRRO) | -17.55% | $135M | -1.53 | - | - | 0% |
 Paratek Pharmaceuticals Inc (PRTK) | +1.83% | $128M | -2 | - | - | 0% |
 Sensorion SA (ALSEN.PA) | -5.6% | $127M | -4.18 | - | - | 0% |
 Kinnate Biopharma Inc (KNTE) | 0% | $125M | -1.09 | - | - | 0% |
 ProQR (PRQR) | -15.71% | $124M | -3.38 | - | - | 0% |
 OSE Immunotherapeutics SA (OSE.PA) | -12.54% | $123M | 3.01 | - | - | 0% |
 Recro Pharma Inc (SCTL) | 0% | $122M | -7.58 | - | - | 0% |
 scPharmaceuticals (SCPH) | -16.4% | $117M | -1.22 | - | - | 0% |
 Regulus Therapeutics (RGLS) | -2.6% | $112M | -1.92 | - | - | 0% |
 Tonix (TNXP) | -22.46% | $108M | -0.53 | - | - | 0% |
 Nektar (NKTR) | -25.25% | $103M | -0.95 | - | - | 0% |
 Enanta Pharmaceuticals (ENTA) | -17.16% | $101M | -0.96 | - | - | 0% |
 Maat Pharma SA (MAAT.PA) | -7.87% | $98.9M | -2.74 | - | - | 0% |
 Vistin Pharma ASA (VISTN.OL) | -3.67% | $97.2M | 16.68 | - | - | 0% |
 Optinose (OPTN) | -0.55% | $92.1M | -3.1 | - | - | 0% |
 Coherus (CHRS) | -6.77% | $90.6M | 4.48 | - | - | 0% |
 Genelux (GNLX) | -22.4% | $90.2M | -2.49 | - | - | 0% |
 Immunic (IMUX) | -17.08% | $89.7M | -0.96 | - | - | 0% |
 Cellectis SA (ALCLS.PA) | -9.39% | $86.7M | -3.22 | - | - | 0% |
 Veru (VERU) | +12.14% | $83.4M | -2.43 | - | - | 0% |
 Cellectis SA (CLLS) | -9.45% | $82.9M | -3.09 | - | - | 0% |
 Tenaya Therapeutics (TNYA) | -22.35% | $81.1M | -0.38 | - | - | 0% |
 Adverum (ADVM) | -16.27% | $80.3M | -0.64 | - | - | 0% |
 Biomea Fusion (BMEA) | -7.83% | $79.7M | -0.55 | - | - | 0% |
 Dormant11642 (Dormant11642) | +46.34% | $75M | -1.52 | - | - | 0% |
 IGM Biosciences (IGMS) | -8.87% | $67.5M | -0.35 | - | - | 0% |
 Sagimet Biosciences (SGMT) | -43.94% | $67M | -1.44 | - | - | 0% |
 Adocia SA (ADOC.PA) | -10.79% | $66.9M | -2.25 | - | - | 0% |
 MacroGenics (MGNX) | -15.87% | $66.9M | -0.99 | - | - | 0% |
 Essa Pharma (EPIX) | -5.13% | $65.7M | -2.11 | - | - | 0% |
 Nykode Therapeutics ASA (NYKD.OL) | -11.28% | $61.6M | -1.61 | - | - | 0% |
 Corbus Pharmaceuticals (CRBP) | -9.06% | $61.4M | -1.37 | - | - | 0% |
 Assertio (ASRT) | -9.32% | $60.1M | -2.77 | - | - | 0% |
 Acumen (ABOS) | -17.82% | $59.2M | -0.57 | - | - | 0% |
 Inovio (INO) | -9.83% | $57.2M | -0.39 | - | - | 0% |
 Venture Life (VLG.L) | -0.72% | $56.4M | 58.05 | - | - | 0% |
 Eco Animal Health (EAH.L) | -2.33% | $54.9M | 64.95 | - | - | 0% |
 Adicet Bio (ACET) | -23.07% | $52.8M | -0.48 | - | - | 0% |
 Inozyme (INZY) | -10.76% | $52.8M | -0.51 | - | - | 0% |
 I-Mab (IMAB) | -19.17% | $52.4M | -0.96 | - | - | 0% |
 Zomedica (ZOMDF) | -8.79% | $51.8M | -1.1 | - | - | 0% |
 Applied Therapeutics (APLT) | -15.77% | $50.6M | -0.33 | - | - | 0% |
 Immuneering (IMRX) | -14.02% | $50.6M | -0.69 | - | - | 0% |
 Verrica (VRCA) | +22.42% | $48.7M | -0.35 | - | - | 0% |
 Abionyx Pharma SA (ABNX.PA) | -5.32% | $45.9M | -9.24 | - | - | 0% |
 Sutro (STRO) | -26.45% | $45.4M | -0.18 | - | - | 0% |
 PDS Biotechnology (PDSB) | -24.6% | $43.1M | -0.92 | - | - | 0% |
 Repare Therapeutics (RPTX) | -4.77% | $42.5M | -0.5 | - | - | 0% |
 Reneo Pharmaceuticals (OKUR) | -29.82% | $42.1M | -0.44 | - | - | 0% |
 Immix Biopharma (IMMX) | -11.76% | $41.6M | -1.89 | - | - | 0% |
 Ocuphire (IRD) | -12.27% | $40.3M | -0.45 | - | - | 0% |
 Actinium (ATNM) | -28.73% | $40.2M | -1.01 | - | - | 0% |
 Shield Therapeutics (STX.L) | +7.14% | $40.2M | -0.79 | - | - | 0% |
 Outlook Therapeutics (OTLK) | -9.09% | $39.1M | -0.15 | - | - | 0% |
 Dormant11628 (Dormant11628) | +40.35% | $38.9M | 2.86 | - | - | 0% |
 Milestone Pharmaceuticals (MIST) | -20.94% | $37.1M | -0.96 | - | - | 0% |
 Sio Gene Therapies Inc (SIOX) | +22.88% | $35.4M | -1.22 | - | - | 0% |
 China SXT (SXTC) | -10.87% | $33.7M | 0.9 | - | - | 0% |
 Poolbeg Pharma (POLB.L) | +0.98% | $33.1M | -5.85 | - | - | 0% |
 Atara (ATRA) | -14.4% | $32.8M | -0.43 | - | - | 0% |
 Scynexis (SCYX) | -16% | $32.7M | -1.81 | - | - | 0% |
 Acasti Pharma (GRCE) | +3.67% | $31.5M | -2.55 | - | - | 0% |
 Lytix Biopharma AS (LYTIX.OL) | -0.6% | $31.5M | -2.57 | - | - | 0% |
 Werewolf Therapeutics (HOWL) | -32.2% | $31.3M | -0.43 | - | - | 0% |
 Marinus Pharmaceuticals (MRNS) | 0% | $29.6M | -0.22 | - | - | 0% |
 Synairgen (SNG.L) | +3.38% | $29.3M | -0.6 | - | - | 0% |
 Gensight Biologics SA (SIGHT.PA) | -9.33% | $28.6M | -1.36 | - | - | 0% |
 Allakos (ALLK) | +36.9% | $28.4M | -0.24 | - | - | 0% |
 Tempest (TPST) | -20.46% | $27.9M | -0.41 | - | - | 0% |
 Kala Bio (KALA) | -29.92% | $27.4M | -0.38 | - | - | 0% |
 Arecor (AREC.L) | -6.84% | $26.5M | -1.93 | - | - | 0% |
 Annovis Bio (ANVS) | -20.61% | $25.5M | -0.66 | - | - | 0% |
 Generation Bio (GBIO) | -12.93% | $25M | -0.19 | - | - | 0% |
 Reviva (RVPH) | -47.52% | $24.7M | -0.59 | - | - | 0% |
 Eagle (EGRX) | +114.2% | $24.5M | 4.1 | - | - | 0% |
 VYNE (VYNE) | -8.24% | $23.7M | -1.67 | - | - | 0% |
 Ovid Therapeutics (OVID) | -19.54% | $20M | -0.76 | - | - | 0% |
 Nicox SA (ALCOX.PA) | -7.17% | $18.1M | -0.65 | - | - | 0% |
 Lipocine (LPCN) | -8.23% | $16.1M | 590.2 | - | - | 0% |
 Cocrystal Pharma (COCP) | -4.05% | $14.4M | -0.83 | - | - | 0% |
 Palatin Technologies (PTN) | -22.75% | $13.3M | -0.33 | - | - | 0% |
 Poxel SA (POXEL.PA) | -11.57% | $12.6M | -0.54 | - | - | 0% |
 Moleculin (MBRX) | -21.15% | $11.6M | -0.12 | - | - | 0% |
 Valerio Therapeutics SA (ALVIO.PA) | -0.15% | $11M | -0.53 | - | - | 0% |
 NextCure (NXTC) | -21.82% | $10.9M | -0.2 | - | - | 0% |
 Bivictrix Therapeutics Plc (BVX.L) | +33.33% | $10.6M | -2.84 | - | - | 0% |
 Immuron (IMRN) | -3.78% | $10.4M | -2.09 | - | - | 0% |
 TherapeuticsMD (TXMD) | -9.96% | $10.2M | -4.68 | - | - | 0% |
 Minerva Neurosciences (NERV) | -24.31% | $9.58M | 7.21 | - | - | 0% |
 Relmada (RLMD) | -8.19% | $9.04M | -0.1 | - | - | 0% |
 AcelRx (ACRX) | -12.82% | $8.74M | -1.01 | - | - | 0% |
 Aton SA (ALTAO.PA) | -4.08% | $8.22M | - | - | - | 0% |
 Aeterna Zentaris (AEZS) | -15.78% | $8M | -0.1 | - | - | 0% |
 Lyra (LYRA) | -13.17% | $7.95M | -0.08 | - | - | 0% |
 Oncodesign Precision Medicine Opm SA (ALOPM.PA) | -5.13% | $7.34M | -0.93 | - | - | 0% |
 AIM ImmunoTech (AIM) | -21.57% | $6.86M | -0.3 | - | - | 0% |
 Intec Parent (INDP) | -21.73% | $6.66M | -0.29 | - | - | 0% |
 Aytu BioScience (AYTU) | -14.88% | $6.36M | -0.71 | - | - | 0% |
 Phaxiam Therapeutics SA (PHXM.PA) | -21.51% | $6.05M | -0.16 | - | - | 0% |
 Bergenbio ASA (BGBIO.OL) | -14.99% | $5.68M | -0.32 | - | - | 0% |
 Conduit (CDT) | -27.45% | $4.3M | -0.03 | - | - | 0% |
 Oragenics (OGEN) | -13.37% | $4.02M | -0.1 | - | - | 0% |
 Destiny Pharma (DEST.L) | -29.41% | $3.69M | -0.48 | - | - | 0% |
 Theranexus SA (ALTHX.PA) | +1.65% | $3.61M | -1.07 | - | - | 0% |
 Titan Pharmaceuticals (TTNP) | -0.52% | $3.35M | -0.7 | - | - | 0% |
 Valirx (VAL.L) | -10% | $3.25M | -0.39 | - | - | 0% |
 Roquefort Therapeutics Plc (ROQ.L) | -4.48% | $3.19M | -1.34 | - | - | 0% |
 NovaBay (NBY) | -15% | $3.01M | -0.07 | - | - | 0% |
 Jaguar Health (JAGX) | -12.6% | $2.95M | -0.02 | - | - | 0% |
 Genprex (GNPX) | +23.57% | $2.85M | -0.04 | - | - | 0% |
 Matinas BioPharma (MTNB) | -1.87% | $2.7M | -0.12 | - | - | 0% |
 Dormant11432 (Dormant11432) | -43.9% | $1.61M | -0.26 | - | - | 0% |
 Ovoca Bio (OVB.L) | 0% | $1.42M | -0.36 | - | - | 0% |
 Trevena (TRVN) | -4% | $1.04M | -0.03 | - | - | 0% |
 bioXXmed AG (T5O0.DE) | -18.11% | $892K | - | - | - | 0% |
 Scorpius Holdings (SCPX) | -10.63% | $770K | 0 | - | - | 0% |
 Acorda (ACOR) | -10% | $16.8K | 0 | - | - | 0% |
 Neovacs SA (ALNEV.PA) | -31.83% | $12K | 0 | - | - | 0% |
 Evelo (EVLO) | 0% | $9.5K | 0 | - | - | 0% |
 Zosano Pharma Corp (ZSANQ) | -66.67% | $1K | 0 | - | - | 0% |
 Ampio (AMPE) | 0% | $700 | 0 | - | - | 0% |
 Nabriva (NBRVF) | 0% | $300 | 0 | - | - | 0% |
 Allena Pharmaceuticals (ALNA) | 0% | $100 | 0 | - | - | 0% |